Bioterrorism: From threat to reality

Annual Review of Microbiology

Volumn 56, Issue , 2002, Pages 167-185

  Atlas, Ronald M ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Anthrax; Biological weapon; Microorganism; Smallpox; Toxin

Indexed keywords

ANTHRAX; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; BOTULISM; DISEASE TRANSMISSION; FRANCISELLA TULARENSIS; HUMAN; INFECTION CONTROL; LAW ENFORCEMENT; PLAGUE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SMALLPOX; TULAREMIA; UNITED STATES; YERSINIA PESTIS; ANIMAL; BACTERIAL INFECTION; CATTLE; CLASSIFICATION; PATHOLOGY;

ANTHRAX; BACILLUS ANTHRACIS; FRANCISELLA TULARENSIS; VARIOLA VIRUS; YERSINIA; YERSINIA PESTIS;

CIPROFLOXACIN;

ANIMALS; ANTHRAX; BACTERIAL INFECTIONS; BIOTERRORISM; BOTULISM; CATTLE; CIPROFLOXACIN; HUMANS; PLAGUE; SMALLPOX; TULAREMIA;

EID: 0036053928     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.micro.56.012302.160616     Document Type: Review

References (58)

1. Abramova F, Grinberg L, Yampolskaya O, Walker D. 1993. Pathology of inhalational anthrax in forty-two cases from the Sverdlovsk outbreak of 1979. Proc. Natl. Acad. Sci. USA 90:2291-94
2. Advisory Committee on Immunization Practices. 2001. Vaccinia (smallpox) vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 50:1-25
3. Alibek K. 1999. Biohazard. New York: Random House
4. Anonymous. 1966. Deliberate spreading of typhoid in Japan. Sci. J. 2(10):11, 13
5. Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, et al. (Working Group on Civilian Biodefense). 2001. Botulinum toxin as a biological weapon: Medical and public health management. JAMA 285:1059-70
6. Atlas R. 1998. Biological weapons pose challenge for microbiology community: Microbiologists should help shape policies protecting against biological weapons but safeguarding legitimate research. ASM News 64:383-89
7. Bardi J. 1999. Aftermath of a hypothetical smallpox disaster. Emerg. Infect. Dis. 5:547-51
8. Betts RK. 1998. The new threat of mass destruction. Foreign Aff. 77:26-42
9. Bolton JR. 2001. 5th Biological Weapons Convention Rev Con Meeting, Biological Weapons Convention Remarks, Geneva November 19. http://www.state.gov/t/us/rm/2001/index.cfm?docid=6231
10. Borio L, Frank D, Mani V, Chiriboga C, Pollanen M, et al. 2001. Death due to bioterrorism-related inhalational anthrax report of 2 patients. JAMA 286:2554-59
11. Brookmeyer R, Blades N. 2002. Prevention of inhalational anthrax in the U.S. outbreak. Science 295:1861
12. Centers for Disease Control and Prevention. 2001. Executive Summary for Interim Smallpox Response Plan & Guidelines Plus ACIP Vaccine Recommendations. http://www.cdc.gov/nip/diseases/smallpox
13. Centers for Disease Control and Prevention. 2001. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy. MMWR 50:909-19
14. Cieslak TJ, Eitzen EM. 1999. Clinical and epidemiologic principles of anthrax. Emerg. Infect. Dis. 5:552-55
15. Ciluffo FJ, Cardash SL, Lederman GN. 2000. Combating Chemical, Biological, Radiological and Nuclear Terrorism: A Comprehensive Strategy. Washington, DC: Cent. Strategic Int. Studies
16. Danzig R, Berkowsky PB. 1997. Why should we be concerned about biological warfare? JAMA 278:431-32
17. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, et al. (Working Group on Civilian Biodefense). 2001. Tularemia as a biological weapon: Medical and public health management. JAMA 285:2763-73
18. Department of Defense. 2001. Proliferation: Threat and Response. http://www.defenselink.mil/news/Jan2001/b01102001_ bt010-01.html
19. Eitzen E, Pavlin J, Cieslak T, Christopher G, Culpepper R, eds. 1998. Medical Management of Biological Casualties Handbook. Fort Dietrick, MD: USAMRIID
20. Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, et al. 1997. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 278:399-411
21. Guillemin J. 1999. Anthrax: The Investigation of a Deadly Outbreak. Berkeley: Univ. Calif. Press
22. Henderson DA. 1999. Smallpox: Clinical and epidemiologic features. Emerg. Infect. Dis. 5:537-39
23. Henderson DA, Inglesby TV, Bartlet JG, Ascher MS, Eitzen E, et al. 1999. Smallpox as a biological weapon: Medical and public health management. JAMA 281:2127-37
24. Hoffman RE, Norton JE. 2000. Lessons learned from a full-scale exercise. Emerg. Infect. Dis. 6:652-53
25. Humbaugh KE. 2001. Discussion of the Lessons Learned from the Recent CDC Bioterrorism Exercise Held in Louisville. http://www.louisville.edu/medschool/cme/bioterrorismwebcast.html
26. Inglesby TV. 1999. Anthrax: A possible case history. Emerg. Infect. Dis. 5:556-60
27. Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, et al. (Working Group on Civilian Biodefense). 2000. Plague as a biological weapon: Medical and public health management. JAMA 283:2281-90
28. Ingleby T, Grossman R, O'Toole T. 2001. A plague on your city: Observations from TOPOFF. Clin. Infect. Dis. 32:436-45
29. Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. (Working Group on Civilian Biodefense). 1999. Anthrax as a biological weapon: Medical and public health management. JAMA 281:1735-45
30. Jackson PJ, Hugh-Jones ME, Adair DM, Green G, Hill KK, et al. 1998. PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: The presence of multiple Bacillus anthracis strains in different victims. Proc. Natl. Acad. Sci. USA 95:1224-29
31. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Martin S, et al. 2001. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States. Emerg. Infect. Dis. 7:933-44
32. Kaplan DE. 2000. Aum Shinrikyo. See Ref. 55, pp. 207-26
33. Khan AS, Sage MJ. 2000. Biological and chemical terrorism: Strategic plan for preparedness and response. MMWR 49:1-14
34. Kolavic S, Kimura A, Simons S, Slutsker L, Barth S, Haley C. 1997. An outbreak of Shigella dysenteriae Type 2 among laboratory workers due to intentional contamination. JAMA 278:396-98
35. Kortepeter MG, Parker GW. 1999. Potential biological weapons threats. Emerg. Infect. Dis. 5:523-27
36. Lane CL, Fauci AS. 2001. Bioterrorism on the home front: A new challenge for American medicine. JAMA 286:2595-98
37. Mayer TA, Bersoff-Matcha S, Murphy C, Earls J, Harper S, et al. 2001. Clinical presentation of inhalational anthrax following bioterrorism exposure report of 2 surviving patients. JAMA 286:2549-53
38. Meselson M, Guillemin J, Hugh-Jones M Langmuir A, Popova I, et al. 1994. The Sverdlovsk anthrax outbreak of 1979. Science 266:1202-8
39. Nowak R. 2001. Disaster in the making. New Sci. 169:4
40. Olson KB. 1999. Aum Shinrikyo: Once and future threat? Emerg. Infect. Dis. 5:513-16
41. Osterholm M. 1997. The silent killers. Newsweek 130(20):32-33
42. Osterholm MT, Schwartz J. 2000. Living Terrors: What America Needs to Know to Survive the Coming Bioterrorist Catastrophe. New York: Delacorte
43. O'Toole T. 1999. Smallpox: An attack scenario. Emerg. Infect. Dis. 5:540-46
44. O'Toole T, Inglesby T. 2001. Shining Light on Dark Winter. www.hopkins-biodefense.org/lessons.html
45. Pearson GS. 1998. The Threat of Deliberate Disease in the 21st Century. Henry L. Stimson Center Report, No.24. Washington, DC: Stimson Cent.
46. Poupard JA, Miller LA. 1992. History of biological warfare: Catapults to capsomeres. Ann. NY Acad. Sci. 666:9-20
47. Russo E. 2001. Bioterrorism preparedness. Scientist 15:1
48. Schupp JM, Klevytska AM, Zinser G, Price LB, Keim P. 2000. vrrB, a hypervariable open reading frame in Bacillus anthracis. J. Bacteriol. 182:3989-97
49. Shapiro R, Hatheway C, Becher J, Swerdlow D. 1997. Botulism surveillance and emergency response. JAMA 278:433-35
50. Shapiro R, Hatheway C, Swerdlow D. 1998. Botulism in the United States: A clinical and epidemiologic review. Ann. Intern. Med. 129:221-28
51. Siegrist DW. 1999. The threat of biological attack: Why concern now? Emerg. Infect. Dis. 5:505-8
52. Stem J. 1999. The Ultimate Terrorists. Boston: Harvard Univ. Press
53. Stem J. 1999. The prospect of domestic bioterrorism. Emerg. Infect. Dis. 5:517-22
54. Török T, Tauxe R, Wise R, Livengood J, Sokolow R, et al. 1997. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA 278:389-95
55. Tucker JB. 1999. Historical trends related to bioterrorism: An empirical analysis. Emerg. Infect. Dis. 5:498-504
56. Tucker JB, ed. 2000. Toxic Terror: Assessing Terrorist Use of Chemical and Biological Weapons. Boston: MIT Press
57. Wade N. 1980. Death at Sverdlovsk: A critical diagnosis. Science 209:1501-2
58. WHO Group of Consultants. 1970. Health Aspects of Chemical and Biological Weapons. Geneva: WHO